TFTC on Nostr: Bank of America is spending $250 million a year on Ozempic and GLP-1 weight loss ...
Bank of America is spending $250 million a year on Ozempic and GLP-1 weight loss drugs for employees.
CEO Brian Moynihan calls it a good investment in workforce health and productivity.
Published at
2026-08-06 21:41:29 UTCEvent JSON
{
"id": "cef28c769a118cb4aa7c3551a350018c94564f453374922cd572cdca46330b86",
"pubkey": "85bdb5875e113dcc99498b474636449882ee15a1c78154ab07c065b47339d672",
"created_at": 1786052489,
"kind": 1,
"tags": [
[
"imeta",
"url https://blossom.primal.net/f2b1d7aaa9a2ef0f2d3224c3b87f73661dfd456572f2f4626b8a8cc30b344ab9.png",
"m image/png",
"x f2b1d7aaa9a2ef0f2d3224c3b87f73661dfd456572f2f4626b8a8cc30b344ab9",
"size 111969"
]
],
"content": "Bank of America is spending $250 million a year on Ozempic and GLP-1 weight loss drugs for employees.\n\nCEO Brian Moynihan calls it a good investment in workforce health and productivity.\nhttps://blossom.primal.net/f2b1d7aaa9a2ef0f2d3224c3b87f73661dfd456572f2f4626b8a8cc30b344ab9.png",
"sig": "3f2c56920ea0f5916d998adaf3fba484de4a9638c58457c57dff7b94d4326bbe601383a045ef1d303d5ff0910de94a9e4474f12ef9efe94ef2128803128f3432"
}
